IDYA - חוב לטווח קצר להון IDEAYA Biosciences, Inc.

Current price action for IDEAYA Biosciences (IDYA) demonstrates the 0.00 indicator. The development of this business is independent of market cycles, as demand for oncology treatments remains stable and is driven by test results. IDEAYA Biosciences (IDYA) employs an asset-light strategy, outsourcing drug production to third-party contractors, while the research process is based on close collaboration with specialized organizations under strict internal supervision.

This ratio measures the proportion of liabilities maturing within one year relative to equity, allowing for an assessment of liquidity risk and the probability of cash flow gaps during fundamental analysis. By analyzing the change in short-term debt to equity, an investor can determine the extent to which the financial stability of IDEAYA Biosciences (IDYA) ensures the uninterrupted operation of laboratories and the fulfillment of molecule synthesis contracts.